RxDoctor Payments Data

Abdisamad Ibrahim, MD

Interventional Cardiology · Robbinsdale, MNNPI 1922538834

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 78.7% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $4,026, more than ten times the $160 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.

$5,243in general payments, 2019–2025

Across 58 payments — averaging $90.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Abbott$676
  • W. L. Gore & Associates, Inc.$151
  • Johnson & Johnson$111
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$50
  • Dova Pharmaceuticals$49
  • plus $82 from 4 others

What the payments were for

  • Travel & lodging$2,57949%
  • Food & beverage$1,82135%
  • Education$84316%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,243 in reported general payments places this provider in the 45th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$1,409
Medicare patients
11
Services billed
17

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate37$431

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Robbinsdale

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →